Movement Disorders in the World of COVID-19

Affiliations

¹ Pacific Parkinson's Research Centre & Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
² Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom.
³ Raul Carrea Institute of Neurological Research, Movement Disorders Unit, FLENI, Ciudad Autónoma de Buenos Aires, Argentina.

Editorial

A Jon Stoessl et al. Mov Disord. 2020 May.

. 2020 May;35(5):709-710.

doi: 10.1002/mds.28069. Epub 2020 Apr 16.

¹ Pacific Parkinson's Research Centre & Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.
² Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom.
³ Raul Carrea Institute of Neurological Research, Movement Disorders Unit, FLENI, Ciudad Autónoma de Buenos Aires, Argentina.

No abstract available

References

1. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020 Feb 27. doi: https://doi.org/10.1002/jmv.25728. [Epub ahead of print]
1. Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol 2008;82:7264-7275.
1. Doobay MF, Talman LS, Obr TD, Tian X, Davisson RL, Lazartigues E. Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 2007;292:R373-R381.
1. Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H. The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med 1995;181:2161-2169.
1. Sadasivan S, Sharp B, Schultz-Cherry S, Smeyne RJ. Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: experimental evidence for the multi-hit hypothesis. NPJ Parkinsons Dis 2017;3:18.